4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
SC 236,
SC 58236,
SC-236,
SC-58236,
SC236,
SC58236,
170569-86-5,
SC-236,
SC 236,
SC236,
SC-58236,
SC 58236,
4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide,
4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide,
CHEMBL282093,
4-[5-(4-chlorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,
NSQNZEUFHPTJME-UHFFFAOYSA-N,
UNII-9HGW1H8S2M,
9HGW1H8S2M,
SCHEMBL215932,
CTK6G9656,
GTPL10242,
DTXSID80432082,
HMS3262A06,
ZINC600558,
Tox21_500722,
BDBM50057527,
AKOS024457872,
compound 1f [PMID: 9135032],
API0008437,
CCG-222026,
NCGC00261407-01,
NCGC00370982-02,
LS-31451,
RT-015669,
SC-236, >=98% (HPLC),
B7533,
FT-0674529,
J-010629,
4-[5(4-chlorophenyl)-3-trifluoromethyl-1H-pyrazol-1yl]benzenesulfonamide,
4-[5-(4-Chloro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide,
4-[5-(4-chlorophenyl)-3-trifluoromethyl-1h-pyrazol-1-yl]benzenesulfonamide,
4-[5-(4-chlorophenyl)-3-trifluoromethyl-1H-pyrazol-1yl]benzenesulfonamide,
4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl] benzenesulfonamide,
4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide,
D03NZV,
SC-791,
SC-872,
CID9865808,
SC58236,
COX-2 inhibitors (anticancer), Pfizer,
COX-2 inhibitors (anticancer), Pharmacia,
C119130,